Subject to the Independent Expert determining that the Scheme is in the best interests of ResApp
shareholders, and in the absence of a superior proposal, the Directors of ResApp unanimously
recommend that ResApp shareholders vote in favour of the Scheme and intend to vote shares in
their control in favour of the proposed Scheme.
- Forums
- ASX - By Stock
- Ann: Proposed Acquisition of ResApp Health by Pfizer
Subject to the Independent Expert determining that the Scheme is...
-
-
- There are more pages in this discussion • 535 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
|
|||||
Last
20.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $176.2M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
RAP (ASX) Chart |
Day chart unavailable
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, CEO
Paul Long
CEO
Previous Video
Next Video
SPONSORED BY The Market Online